Intrathecal Trastuzumab as a Novel Simplified Therapeutic Strategy for Isolated Metastases in the Leptomeninges in HER2-Positive Breast Cancer: A Case Report and Review of Literature

Leptomeningeal metastases is one of the dreaded complications of metastatic breast cancer, which has a very poor prognosis despite standard treatment, which includes systemic chemotherapy, targeted therapy, and radiation therapy. Intrathecal (IT) therapy has also been used in various studies, which...

Full description

Saved in:
Bibliographic Details
Main Authors: Lokesh K. Nagendrappa, Ananda N. Shankaranarayana, Beulah E. Koshy, Suresh Babu, Rudresha A. H., Rajeev L. Krishnappa, Smitha Saldanha, Ajinkya D. Pophale
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809447
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Leptomeningeal metastases is one of the dreaded complications of metastatic breast cancer, which has a very poor prognosis despite standard treatment, which includes systemic chemotherapy, targeted therapy, and radiation therapy. Intrathecal (IT) therapy has also been used in various studies, which includes IT methotrexate and IT trastuzumab (if the cancer is found to be HER2 + ).
ISSN:0971-5851
0975-2129